Operational research to develop an M&E strategy to guide triple drug stopping decisions for lymphatic filariasis in Egypt
What is the indicator(s) and accompanying monitoring and evaluation (M&E) strategy that enables country programs to determine when the risk of ongoing transmission of LF has been reduced so that IDA can be stopped with little risk of resurgence of transmission?
Atris and Giza, Egypt
Total sample size: 2000 Human
Principal Investigator is independent consultant Dr. Reda Ramzy, with funding administered through The Eastern Mediterranean Public Health Network (EMPHNET).